Experimental models are needed that simulate the progression of NAFLD to HCC in conditions similar to those in clinical practice, and dependence of the roles of adiponectin and leptin on sex must be considered. This evidence concerns the gene LEP and metabolic dysfunction-associated steatotic liver disease.